i10 Productivity
Rankings
AstraZeneca, Sweden ScientistsOthers i10 Productivity Rankings 2025
Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Additionally, click to view the special rankings based on Productivity Rankings: last 6 years' i10 index", Universities Rankings 2024 (Sort by : Total i10 Index), Universities Rankings 2024 (Sort by : Last 6 Years i10 Index) "Art and Humanities Rankings" and "Social Sciences and Humanities Rankings".
* Total i10 IndexRankings
Ranking Based On Selection :1
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
244
129
0.529
* Total i10 IndexRankings
Ranking Based On Selection :2
Drug metabolism and disposition
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
177
77
0.435
* Total i10 IndexRankings
Ranking Based On Selection :3
Cancer
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
110
51
0.464
* Total i10 IndexRankings
Ranking Based On Selection :4
Clinical Trials
Longitudinal Data
Evidence Synthesis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
109
99
0.908
* Total i10 IndexRankings
Ranking Based On Selection :5
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
103
72
0.699
* Total i10 IndexRankings
Ranking Based On Selection :6
drug discovery and development
viruses and epithelial biology
non coding RNA
post translational modification
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
99
63
0.636
* Total i10 IndexRankings
Ranking Based On Selection :7
meta-analysis
missing data
statistics
biostatistics
miscellaneous statistical theory
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
95
83
0.874
* Total i10 IndexRankings
Ranking Based On Selection :8
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
94
79
0.840
* Total i10 IndexRankings
Ranking Based On Selection :9
Cardiovascular
Drug Discovery & Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
81
40
0.494
* Total i10 IndexRankings
Ranking Based On Selection :10
Early Phase Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
80
62
0.775
* Total i10 IndexRankings
Ranking Based On Selection :11
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
80
48
0.600
* Total i10 IndexRankings
Ranking Based On Selection :12
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
77
48
0.623
* Total i10 IndexRankings
Ranking Based On Selection :13
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
71
63
0.887
* Total i10 IndexRankings
Ranking Based On Selection :14
MS imaging
molecular imaging
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
70
66
0.943
* Total i10 IndexRankings
Ranking Based On Selection :15
Diabetes
Cardiovascular disease
Heart failure
Kidney disease
Hypertension
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
70
59
0.843
* Total i10 IndexRankings
Ranking Based On Selection :16
Sustainability
Environmental Risk Assessment
Persistence Assessment
Antimicrobial Resistance
Biodegradability
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
69
57
0.826
* Total i10 IndexRankings
Ranking Based On Selection :17
Lipoproteins
Coronary artery disease
Heart failure
Inflammation
Cardiovascular disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
67
61
0.910
* Total i10 IndexRankings
Ranking Based On Selection :18
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
66
49
0.742
* Total i10 IndexRankings
Ranking Based On Selection :19
Drug discovery and development
Nucleotide therapeutics
Targeted drug delivery
chirality
drug metabolism
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
64
38
0.594
* Total i10 IndexRankings
Ranking Based On Selection :20
arrhythmias
heart failure
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
64
20
0.313
* Total i10 IndexRankings
Ranking Based On Selection :21
Lymphocyte Biology
Lymphomagenesis
Therapeutics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
62
51
0.823
* Total i10 IndexRankings
Ranking Based On Selection :22
Molecular imaging
Drug discovery and development
Radiochemistry
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
60
36
0.600
* Total i10 IndexRankings
Ranking Based On Selection :23
drug discovery
kinase
cell biology
Alzheimer's disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
59
29
0.492
* Total i10 IndexRankings
Ranking Based On Selection :24
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
57
24
0.421
* Total i10 IndexRankings
Ranking Based On Selection :25
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
56
49
0.875
Outi Vaarala
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
244
129
0.529
Tommy B Andersson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
177
77
0.435
Cristiano Ferlini
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
110
51
0.464
Michael Sweeting
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
109
99
0.908
Mark Birrell
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
103
72
0.699
Rose A Maciewicz
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
99
63
0.636
drug discovery and development
viruses and epithelial biology
non coding RNA
post translational modification
Dan Jackson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
95
83
0.874
meta-analysis
missing data
statistics
biostatistics
miscellaneous statistical theory
Mark J O'Connor
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
94
79
0.840
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients
Eva Hurt-Camejo
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
81
40
0.494
Emma Dean
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
80
62
0.775
Carmen Pin
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
80
48
0.600
Scott Hammond
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
77
48
0.623
Bret Sellman
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
71
63
0.887
Richard Ja Goodwin
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
70
66
0.943
Johan Bodegård
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
70
59
0.843
Diabetes
Cardiovascular disease
Heart failure
Kidney disease
Hypertension
Jason R Snape
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
69
57
0.826
Sustainability
Environmental Risk Assessment
Persistence Assessment
Antimicrobial Resistance
Biodegradability
Liang Guo
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
67
61
0.910
Lipoproteins
Coronary artery disease
Heart failure
Inflammation
Cardiovascular disease
Peter Greasley
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
66
49
0.742
Shalini Andersson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
64
38
0.594
Drug discovery and development
Nucleotide therapeutics
Targeted drug delivery
chirality
drug metabolism
Leif Carlsson
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
64
20
0.313
Arthur Shaffer
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
62
51
0.823
Magnus Schou
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
60
36
0.600
Molecular imaging
Drug discovery and development
Radiochemistry
Clay W Scott
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
59
29
0.492
Bernard Barlaam
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
57
24
0.421
Marianne Ashford
AstraZeneca, Sweden
Södertälje, Sweden
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
56
49
0.875